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cant risk of cardiovascular morbidity and mortality
due to underlying symptomatic or asymptomatic cor-
onary artery disease. As was shown by Hertzer et al.
in their landmark study in 1984 of 1000 patients
undergoing noncardiac vascular surgery, 61% of all
patients did have at least one coronary artery with
a stenosis of 50% or more. In fact, only 8% of all
patients did have a normal coronary angiogram.1 Im-
portantly, there was no difference between patients
who presented with an abdominal aneurysm, lower
extremity ischemia, or cerebrovascular disease. More
recent studies using functional tests such as dobut-
amine stress echocardiography confirmed the high
incidence of coronary artery disease in vascular surgi-
cal patients. In a study population of 1097 vascular
surgical patients with at least one cardiac risk factors,
the incidence of wall motion abnormalities at rest was
nearly 50% while one fifth of patients had stress
induced myocardial ischemia.2
Despite these figures, the percentage of patients
with troponin release (34%) in the study of Sarves-
waran et al. in the current issue of the Journal seems
to be extremely high. However, as was already noted
by Landesberg et al. in 1993, over 40% of patients
planned for major vascular surgery experience silent
myocardial ischemia preoperatively as assessed
by continuous 12-lead ECG recording,3 also in
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Kertai et al. previously showed that even low levels
of asymptomatic troponin elevations in the periopera-
tive period are associated with worse long-term out-
come in patients undergoing major vascular
surgery.4,5 As was recently stated by Korff et al. ‘‘car-
diac troponins often are the only indicator of cardiac
pathology in numeric cardiac disease or systemic dis-
ease with cardiac involvement.’’6 The high prevalence
of abnormal cardiac troponin T levels current study of
Sarveswaran et al. seems to support this statement.
Obviously, the consequent important question is:
‘‘If a vascular surgical patient is identified to be at
very high risk cardiac events, what can and needs to
be done to prevent these events?’’ Aggressive treat-
ment by prophylactic coronary revascularization
does not seem to offer any benefit in the majority of
vascular surgical patients at increased risk as was
shown in the CARP trial.7 Adequate beta-blocker ther-
apy (target heart rate of 60e65 beats per minute) on the
other hand seems to be of benefit in both the perioper-
ative period and during long-term follow-up.8,9 Recent
literature also suggests an important role for statins in
vascular surgical patients.10 It is striking that in the
current study only 26% of patients with chronic critical
limb ischemia were on statin therapy at admission. A
similar disturbing low figure was found for beta-
blocker use in the Euro Heart Survey11; a considerable
proportion of vascular surgical patients at high cardiac
risk does not receive adequate beta-blocker therapy,
despite clear clinical guidelines.12 These figures illus-
trate the need for an increased awareness of cardiac
risk of vascular surgical patients and a more rigorous
implementation of practical clinical guidelines.erved.
709Cardiac Troponins as a Risk Stratification ToolCardiac risk stratification is of critical importance
in patients undergoing noncardiac vascular surgery.
Patients do not only benefit from careful perioperative
risk stratification and modification but also from long
term risk stratification and optimal medical and, if
necessary, invasive therapy. The measurement of tro-
ponins might be helpful to identify a group of very
high risk patients. The preoperative work up of vascu-
lar patients should be considered as an excellent op-
portunity to identify patients at increased long-term
risk and treat them appropriately to lower the long-
term risk for cardiovascular events. After all, the
patient should live long enough to enjoy the benefits
of the vascular surgical intervention.
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